Clinical Trials

45 enrolled

Phase 1/2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT07477444 2026-03-20

HER-OIC

29 enrolled

Phase 2/3 Not yet recruiting

Gastroesophageal Cancer

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07425054 2026-02-20

HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

33 enrolled

Anus Neoplasms

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

19 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT07381309 2026-02-02

VVSHIP

114 enrolled

CRC

NCT06952621 2026-01-30

TD-NEOE3V3

390 enrolled

Phase 1/2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT07342725 2026-01-15

Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer

48 enrolled

Pancreatic Cancer Metastatic

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

136 enrolled

Pancreatic Neoplasms

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

38 enrolled

Pancreatic Cancer Liver Metastases

NCT07296666 2025-12-22

Adjuvant Chemotherapy for BTC Based on 3D-PTA

98 enrolled

Cholangiocarcinoma

NCT07284394 2025-12-16

PACHA-02

272 enrolled

Colorectal Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

320 enrolled

Pancreatic Neoplasms

NCT07161115 2025-09-15

REFIRT

60 enrolled

Rectal Neoplasms

NCT07134101 2025-08-29

SMARTi-RC01

138 enrolled

Disease, Colorectal Neoplasms

NCT07114666 2025-08-11

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

12 enrolled

Pancreatic Neoplasms

NCT07098949 2025-08-01

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

346 enrolled

Recurrence, Stomach Neoplasms

NCT07097064 2025-07-31

RAIPANC

160 enrolled

Locally Advanced Pancreatic Adenocarcinoma

NCT07027436 2025-06-18

DARTS

30 enrolled

Phase 2/3 Not yet recruiting

Carcinoma, Hepatocellular

NCT07000253 2025-06-02

OMEC-5

290 enrolled

Phase 1 Not yet recruiting

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT04062721 2025-04-06

LICoRN-01

12 enrolled

Phase 1/2 Not yet recruiting

Colorectal Neoplasms

NCT06866977 2025-03-10

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT06814158 2025-02-07

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

57 enrolled

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT06665087 2024-10-30

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

110 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT06522542 2024-07-26

Gastric Cancer Complicated With Bleeding

Not yet recruiting

200 enrolled

Stomach Neoplasms

NCT06513221 2024-07-22

A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab

100 enrolled

Colorectal Neoplasms

NCT06464601 2024-06-18

A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

Not yet recruiting

70 enrolled

Stomach Neoplasms

NCT06422156 2024-05-20

Nim-PC-28

73 enrolled

Advanced Pancreatic Cancer

NCT06411171 2024-05-17

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

36 enrolled

Phase 1 Not yet recruiting

Gastroesophageal Junction Cancer

NCT06346808 2024-04-04

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

20 enrolled

Pancreatic Neoplasms

NCT06304545 2024-03-12

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

48 enrolled

Rectal Neoplasms

NCT06152978 2023-12-01

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

182 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05928312 2023-07-20

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

72 enrolled

Advanced Colorectal Cancer

NCT05832385 2023-04-27

Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer

Not yet recruiting

124 enrolled

Anorectal Cancer

NCT05648487 2022-12-16

HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis

46 enrolled

Stomach Neoplasms

NCT05359393 2022-11-14

Miracle-1

52 enrolled

Advanced Rectal Cancer

NCT05611359 2022-11-10

HOPE-1

60 enrolled

Pancreatic Ductal Adenocarcinoma

NCT05244798 2022-10-25

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

420 enrolled

Esophageal Squamous Cell Carcinoma

NCT04384601 2021-07-19

Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer

246 enrolled

Adenocarcinoma, Stomach Neoplasms

NCT04562727 2021-03-04

Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study

668 enrolled

Phase 2/3 Not yet recruiting

Colorectal Neoplasms

NCT04677673 2020-12-21

RJGC-Senile

232 enrolled